Skip to main content
Log in

Effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes

  • Published:
Journal of Huazhong University of Science and Technology [Medical Sciences] Aims and scope Submit manuscript

Summary

The effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes and the possible mechanisms were investigated in this study. 3T3-L1 preadipocytes were cultured in vitro and treated with different concentrations of ghrelin. Proliferation of 3T3-L1 preadipocytes was evaluated by MTT method and mRNA levels of c-myc and thymidine kinase were detected by RT-PCR. Morphological changes of 3T3-L1 preadipocytes were observed and cell differentiation was measured by oil red O staining. The mRNA levels of peroxisome proliferator-activated receptor γ (PPARγ) and CAAT/enhancer binding protein (C/EBPα) in the cells at different differentiation stages were detected by RT-PCR. The results showed that ghrelin at concentrations of 10−7 to 10−15 mol/L could significantly promote preadipocyte proliferation (P<0.05), with the most pronounced effect observed at 10−11 mol/L (P<0.01). Treatment of 3T3-L1 preadipocytes with ghrelin significantly increased the mRNA levels of c-myc and thymidine kinase (P<0.01). Morphological findings demonstrated that the great amount of lipid droplets appeared in the 3T3-L1 preadipocytes treated with ghrelin. Ghrelin could morphologically induce the differentiation of 3T3-L1 preadipocytes into mature adipocytes. Ghrelin significantly increased the mRNA levels of PPARγ and C/EBPα during the differentiation, when compared with control group (P<0.05). The mRNA levels of PPARγ and C/EBPα were obviously up-regulated with the differentiation of preadipocytes after the treatment of ghrelin. There were significant difference in the mRNA levels of PPARγ and C/EBPα on day 2 and day 8 of the differentiation of 3T3-L1 preadipocytes (P<0.01). In conclusion, ghrelin could promote the proliferation and differentiation of 3T3-L1 preadipocytes by increasing the mRNA levels of PPARγ and C/EBPα and therefore enhance the sensitivity of adipocytes against insulin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kadowaki T, Hara K, Yamauchi T, et al. Molecular mechanism of insulin resistance and obesity. Exp Biol Med, 2003,228(10):1111–1117

    CAS  Google Scholar 

  2. Boucher J, Quilliot D, Praderes JP, et al. Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia, 2005,48(3):569–577

    Article  PubMed  CAS  Google Scholar 

  3. Lacquemant C, Vasseur F, Lepretre F, et al. Adipocytokins, obesity and development of type 2 diabetes. Med Sci (Paris), 2005,21:10–18

    Google Scholar 

  4. Kojima M, Hosoda H, Date Y, et al. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature, 1999,402(6762):656–660

    Article  PubMed  CAS  Google Scholar 

  5. Tritos NA, Kokkotou EG. The physiology and potential clinical applications of ghrelin, a novel peptide hormone. Mayo Clin Proc, 2006,81(5):653–660

    Article  PubMed  CAS  Google Scholar 

  6. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab, 2004,89(6):2548–2556

    Article  PubMed  CAS  Google Scholar 

  7. Spiegelman BM, Filer JS. Obesity and the regulation of energy balance. Cell, 2001,104(4):531–543

    Article  PubMed  CAS  Google Scholar 

  8. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol, 2006,6(10):772–783

    Article  PubMed  CAS  Google Scholar 

  9. Kokkoris P, Pi-Sunyer FX. Obesity and endocrine disease. Endocrinol Metab Clin North Am, 2003,32(4):895–914

    Article  PubMed  CAS  Google Scholar 

  10. Poykko SM, Kellokoski E, Horkko S, et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes, 2003, 52(10):2546–2553

    Article  PubMed  Google Scholar 

  11. Vita M, Henriksson M. The Myc oncoprotein as a therapeutic target for human cancer. Semin Cancer Biol, 2006, 16(4):318–330

    Article  PubMed  CAS  Google Scholar 

  12. Zhang XS, Chen TY, Wang XF. Expression of c-myc, Rb and G1 regulation proteins in breast carcinoma. J Diag Pathol, 2004,11(3):159–162

    Google Scholar 

  13. Rosen ED, Hus CH, Wang X, et al. C/EBP alpha induces adipogenesis through PPAR gamma: a unified pathway. Genes Dev, 2002,16(1)22–26

    Article  PubMed  CAS  Google Scholar 

  14. Lehrke M, Lazar MA. The many faces of PPAR gamma. Cell, 2005,123(6):993–999

    Article  PubMed  CAS  Google Scholar 

  15. Zuo Y, Qiang L, Farmer SR. Activation of CCAAT/enhancer-binding protein (C/EBP) alpha expression by C/EBP beta during adipogenesis requires a peroxisome proliferator-activated receptor-gamma-associated repression of HDAC1 at the C/ebp alpha gene promoter. J Biol Chem, 2006,281(12):7960–7967

    Article  PubMed  CAS  Google Scholar 

  16. Ramji DP, Foka P. CCAAT/enhancer-binding proteins: structure, function and regulation. Biochem J, 2002,365(3):561–575

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

This project was supported by a grant from the National Natural Sciences Foundation of China (No. 30600213).

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, J., Lin, H., Cheng, P. et al. Effects of ghrelin on the proliferation and differentiation of 3T3-L1 preadipocytes. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 29, 227–230 (2009). https://doi.org/10.1007/s11596-009-0218-x

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11596-009-0218-x

Key words

Navigation